1. Home
  2. MBC vs FTRE Comparison

MBC vs FTRE Comparison

Compare MBC & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MasterBrand Inc.

MBC

MasterBrand Inc.

N/A

Current Price

$8.59

Market Cap

1.4B

Sector

Industrials

ML Signal

N/A

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

N/A

Current Price

$9.77

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MBC
FTRE
Founded
1954
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2022
2023

Fundamental Metrics

Financial Performance
Metric
MBC
FTRE
Price
$8.59
$9.77
Analyst Decision
Strong Buy
Buy
Analyst Count
1
9
Target Price
$15.00
$15.39
AVG Volume (30 Days)
2.8M
1.9M
Earning Date
05-11-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.21
N/A
Revenue
$2,734,700,000.00
$2,723,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$14.45
$2.96
P/E Ratio
$42.74
N/A
Revenue Growth
1.27
1.00
52 Week Low
$8.73
$3.97
52 Week High
$14.23
$18.67

Technical Indicators

Market Signals
Indicator
MBC
FTRE
Relative Strength Index (RSI) 21.69 30.81
Support Level N/A $9.29
Resistance Level $13.56 $11.41
Average True Range (ATR) 0.59 0.91
MACD -0.26 0.07
Stochastic Oscillator 11.47 33.40

Price Performance

Historical Comparison
MBC
FTRE

About MBC MasterBrand Inc.

MasterBrand Inc operates as a residential cabinet manufacturer in North America. It offers a comprehensive portfolio of residential cabinetry products for the kitchen, bathroom, and other parts of the home. The firm sells its products throughout the United States and Canada through three primary channels: dealers, retailers and builders.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: